thiethylperazine has been researched along with Cranial Nerve Diseases in 1 studies
Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.
Cranial Nerve Diseases: Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiménez-Jiménez, FJ | 1 |
| Vazquez, A | 1 |
| Garcia-Ruiz, P | 1 |
| Garcia-Urra, D | 1 |
| De Seijas, EV | 1 |
1 other study available for thiethylperazine and Cranial Nerve Diseases
| Article | Year |
|---|---|
Chronic hemidystonia following acute dystonic reaction to thiethylperazine.
Topics: Chronic Disease; Cranial Nerve Diseases; Dystonia; Humans; Male; Middle Aged; Neurologic Examination | 1991 |